市場調査レポート
商品コード
1105711
アフラトキシコーシス治療の世界市場規模:治療法別、地域別予測(2022年~2028年)Global Aflatoxicosis Treatment Market Size study, By Treatment, and Regional Forecasts 2022-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
アフラトキシコーシス治療の世界市場規模:治療法別、地域別予測(2022年~2028年) |
出版日: 2022年07月12日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2~3営業日
|
世界のアフラトキシコーシス治療の市場規模は、食品を媒介とする疾病の蔓延、アフラトキシンに対する意識の高まり、政府当局の有利なイニシアチブと資金調達活動の増加、新興諸国における食品貿易の増加などによって促進されています。
一方で、新興国市場におけるインフラや資源の不足が、予測期間における同市場の成長を阻害する可能性があります。
当レポートでは、世界のアフラトキシコーシス治療市場を調査しており、市場の概要、市場分析、治療法・地域別の分析、および競合情勢など、包括的な情報を提供しています。
List of figures
Global Aflatoxicosis Treatment Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Aflatoxicosis is a disease caused by aflatoxin consumption and acute aflatoxicosis. Aflatoxin toxicity found in both humans and animals. Aflatoxins are a family of toxins produced by certain fungi that are found on different agricultural crops such as maize, peanuts, cottonseed, and tree nuts. The main fungi that produce aflatoxins are Aspergillus flavus and Aspergillus parasiticus, which grow in warm and humid regions. Aflatoxin exposure cause various side effects including nausea, vomiting, abdominal pain, convulsions acutely. The growing prevalence of food borne diseases and increasing awareness towards aflatoxins as well as favorable initiatives from government authorities are factors that are accelerating the global market demand. For instance, according to World health Organization (WHO) - as of 2022, globally around 600 million people fall ill after eating contaminated food and 420 000 lost their lives every year. In low- and middle-income countries every year USD 110 billion spent on productivity and medical expenses due to contamination of food. Moreover, favorable initiatives from government authorities would influence the growth of Aflatoxicosis Treatment Market. For instance, April 2019 - U.S. Agency for International Development (USAID)'s Feed the Future Malawi Improved Seed Systems and Technologies (MISST) project handed over the Aflatoxin Testing Laboratory at Chitedze Research Station to the Government of Malawi (GoM). Along with this handover the participants launched two Aflasafe biocontrol products, named Aflasafe MW-MZ01 and Aflasafe MW02 to reduce risk of aflatoxins during crop production and post-harvest. If applied properly, the products can reduce aflatoxins during both crop production and post-harvest. Also, growing number of funding activates from government authorities coupled with increasing food trade in developing countries are anticipated to act as a catalyzing factor for the market demand during the forecast period. However, a lack of infrastructure, and resources in developing regions impede the growth of the market over the forecast period of 2022-2028.
The key regions considered for the global Aflatoxicosis Treatment Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the growing concern over food safety and contamination and presence of leading market players in the region. Whereas, Asia pacific is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as the growing incidences of post-harvest crop loss and funding activities from government authorities in the region, would create lucrative growth prospects for the global Aflatoxicosis Treatment Market across the Asia pacific region.
Major market players included in this report are:
Abbott Laboratories
AbbVie Inc.
AstraZeneca
F. Hoffmann-La Roche Ltd
GlaxoSmithKline plc.
Johnson & Johnson Services, Inc.
Merck & Co.
Pfizer Inc.
Sanofi
Zydus Cadilla
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Treatment:
Aflatoxicosis Treatment by Blood Transfusion
Aflatoxicosis Treatment by Oxygen Therapy
Aflatoxicosis Treatment by Antibiotics
Aflatoxicosis Treatment by Antihistamines
Aflatoxicosis Treatment by Immunosuppressants
Aflatoxicosis Treatment by Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global Aflatoxicosis Treatment Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors